Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Rushnet Inc RSHN

RushNet, Inc. operates under the name HeliosDX. HeliosDX is a national clinical reference laboratory offering high-complexity urine drug testing (UDT), behavioral drug testing, allergy droplet cards, oral fluids, and infectious disease (PCR). The Company provides management services and insurance billing services principally to clinical reference laboratories. It provides PGX testing through... see more

PINL:RSHN - Post Discussion

Rushnet Inc > Rushnet, Inc. and its Subsidiaries Persist in the Climb
View:
Post by AveragePenny on Apr 06, 2022 11:42am

Rushnet, Inc. and its Subsidiaries Persist in the Climb

If you're still left pondering on this decision and asking "why," see the additional supporting highlights to our decision-making process. In a concise presentation of weighing the pros and cons, the decision boils down to this:

Proceeding with the stock consolidation process:

  • would cost the company time and money, and thus, become a detriment to the business
  • is viewed negatively by many investors
  • has at least some potential of becoming an obstacle to:
    • Acquisition of target laboratory
    • Long term goal of $50 million in revenue

By withdrawing from the corporate action process, we:

  • Can move forward with the Acquisition
  • Can move forward with the split off of heliosDX to pursue uplist of heliosDX, resulting in a dividend to RushNet shareholders instead of a consolidation
  • Provide potential share conversions
  • Can reduce Rushnet structure through other means
  • Can explore other possible shareholder incentives to benefit the shareholders and company in the long run
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities